+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Nevirapine"

US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026 - Product Thumbnail Image

US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026

  • Report
  • February 2021
  • 360 Pages
  • United States
From
From
Pregnancy and Anti-Infective Agents - Product Thumbnail Image

Pregnancy and Anti-Infective Agents

  • Book
  • November 2020
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Nevirapine is an antiretroviral drug used to treat HIV/AIDS. It is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that works by blocking the action of the enzyme reverse transcriptase, which is essential for the replication of the virus. Nevirapine is used in combination with other antiretroviral drugs to treat HIV infection. It is also used to prevent mother-to-child transmission of HIV during childbirth. Nevirapine is a widely used drug in the treatment of infectious diseases, particularly HIV/AIDS. It is an important part of combination antiretroviral therapy (cART) and is recommended by the World Health Organization (WHO) for the treatment of HIV infection. Nevirapine is also used to prevent mother-to-child transmission of HIV during childbirth. Nevirapine is available in both generic and branded forms. It is manufactured by several pharmaceutical companies, including Cipla, Mylan, and Teva Pharmaceuticals. It is also available in combination with other antiretroviral drugs, such as efavirenz and lamivudine. In the Nevirapine market, companies such as Cipla, Mylan, and Teva Pharmaceuticals are major players. Other companies include Aurobindo Pharma, Hetero Drugs, and Sun Pharmaceuticals. Show Less Read more